Cerevel Therapeutics Holdings Stock Price History

CERE Stock  USD 41.90  0.09  0.21%   
If you're considering investing in Cerevel Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cerevel Therapeutics stands at 41.90, as last reported on the 25th of April, with the highest price reaching 42.06 and the lowest price hitting 41.87 during the day. Cerevel Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0059, which signifies that the company had a -0.0059% return per unit of risk over the last 3 months. Cerevel Therapeutics Holdings exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cerevel Therapeutics' Mean Deviation of 0.4122, risk adjusted performance of (0.01), and Standard Deviation of 0.6763 to double-check the risk estimate we provide.
  
At present, Cerevel Therapeutics' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 2.2 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 88.2 M. . As of April 25, 2024, Price To Sales Ratio is expected to decline to 39.33. In addition to that, Price Earnings Ratio is expected to decline to -16.67. Cerevel Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0059

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsCERE

Estimated Market Risk

 0.7
  actual daily
6
94% of assets are more volatile

Expected Return

 0.0
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average Cerevel Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cerevel Therapeutics by adding Cerevel Therapeutics to a well-diversified portfolio.
Price Book
11.2787
Book Value
3.715
Enterprise Value
7.1 B
Enterprise Value Ebitda
(16.76)
Shares Float
77.2 M

Cerevel Therapeutics Stock Price History Chart

There are several ways to analyze Cerevel Stock price data. The simplest method is using a basic Cerevel candlestick price chart, which shows Cerevel Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceFebruary 14, 202443.27
Lowest PriceFebruary 23, 202440.88

Cerevel Therapeutics April 25, 2024 Stock Price Synopsis

Various analyses of Cerevel Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cerevel Stock. It can be used to describe the percentage change in the price of Cerevel Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cerevel Stock.
Cerevel Therapeutics Price Rate Of Daily Change 1.00 
Cerevel Therapeutics Accumulation Distribution 2,844 
Cerevel Therapeutics Price Daily Balance Of Power(0.47)
Cerevel Therapeutics Price Action Indicator(0.11)

Cerevel Therapeutics April 25, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Cerevel Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Cerevel Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Cerevel Stock and then apply it to test your longer-term investment strategies against Cerevel.

Cerevel Stock Price History Data

The price series of Cerevel Therapeutics for the period between Fri, Jan 26, 2024 and Thu, Apr 25, 2024 has a statistical range of 2.39 with a coefficient of variation of 1.33. The prices are distributed with arithmetic mean of 41.95. The median price for the last 90 days is 42.1. The company had 1:1 stock split on 28th of October 2020.
OpenHighLowCloseVolume
04/24/2024 41.99  42.06  41.87  41.90  629,646 
04/23/2024 42.10  42.14  41.90  41.99  1,390,239 
04/22/2024 42.28  42.30  41.86  42.10  701,473 
04/19/2024 42.01  42.23  42.00  42.21  813,314 
04/18/2024 41.88  42.21  41.70  42.14  1,254,969 
04/17/2024 41.47  41.80  41.30  41.60  838,023 
04/16/2024 41.60  41.81  41.19  41.31  1,439,526 
04/15/2024 41.83  41.92  41.54  41.70  1,333,538 
04/12/2024 42.02  42.05  41.50  41.85  2,114,740 
04/11/2024 42.17  42.18  42.00  42.01  948,254 
04/10/2024 42.10  42.27  42.04  42.11  1,218,905 
04/09/2024 42.20  42.20  42.04  42.13  748,979 
04/08/2024 42.17  42.28  42.10  42.21  1,057,638 
04/05/2024 42.15  42.28  42.04  42.17  976,840 
04/04/2024 42.31  42.41  42.16  42.17  1,386,066 
04/03/2024 42.35  42.51  42.16  42.33  2,121,146 
04/02/2024 42.30  42.57  42.28  42.35  888,606 
04/01/2024 42.25  42.41  42.21  42.32  721,882 
03/28/2024 42.35  42.38  42.11  42.27  1,058,068 
03/27/2024 42.36  42.52  42.18  42.38  770,629 
03/26/2024 42.48  42.60  42.24  42.36  1,296,694 
03/25/2024 42.20  42.45  42.20  42.40  1,564,304 
03/22/2024 42.30  42.39  42.10  42.19  707,439 
03/21/2024 42.40  42.48  42.21  42.27  735,788 
03/20/2024 42.30  42.49  42.24  42.30  1,066,558 
03/19/2024 42.59  42.70  42.27  42.32  1,535,823 
03/18/2024 42.37  42.80  42.35  42.56  2,821,213 
03/15/2024 42.20  42.42  42.17  42.33  2,499,706 
03/14/2024 42.31  42.41  42.21  42.24  1,782,907 
03/13/2024 41.96  42.29  41.88  42.21  1,519,255 
03/12/2024 41.33  42.05  41.33  41.88  1,556,950 
03/11/2024 41.21  41.49  41.15  41.43  840,286 
03/08/2024 41.37  41.50  41.10  41.25  955,301 
03/07/2024 41.39  41.45  41.23  41.27  945,653 
03/06/2024 41.25  41.39  41.12  41.27  927,553 
03/05/2024 40.99  41.35  40.99  41.22  889,839 
03/04/2024 41.12  41.19  40.80  41.09  924,659 
03/01/2024 41.05  41.28  41.04  41.05  1,690,137 
02/29/2024 41.35  41.35  41.00  41.00  1,110,639 
02/28/2024 41.20  41.28  41.15  41.22  609,810 
02/27/2024 41.01  41.38  40.98  41.31  1,050,878 
02/26/2024 40.90  41.15  40.87  41.08  1,433,326 
02/23/2024 41.14  41.14  40.85  40.88  1,028,297 
02/22/2024 41.00  41.13  40.66  41.06  2,060,210 
02/21/2024 41.03  41.12  40.80  40.93  1,920,800 
02/20/2024 41.23  41.41  41.00  41.04  5,425,533 
02/16/2024 42.93  42.96  42.26  42.57  2,736,490 
02/15/2024 43.50  43.59  42.58  42.93  4,018,752 
02/14/2024 43.00  43.28  43.00  43.27  1,672,022 
02/13/2024 43.00  43.08  42.86  42.89  1,708,870 
02/12/2024 42.82  43.10  42.73  43.10  1,202,301 
02/09/2024 42.22  43.02  42.18  42.88  3,133,525 
02/08/2024 41.85  42.18  41.85  42.18  2,353,215 
02/07/2024 41.70  41.77  41.41  41.53  799,611 
02/06/2024 41.70  41.81  41.50  41.66  1,082,526 
02/05/2024 41.80  41.89  41.62  41.70  1,056,952 
02/02/2024 41.81  42.01  41.78  41.85  699,353 
02/01/2024 41.92  42.00  41.75  41.81  1,025,263 
01/31/2024 42.10  42.24  41.82  41.90  958,198 
01/30/2024 42.05  42.19  41.96  42.09  1,257,573 
01/29/2024 42.09  42.18  42.00  42.01  660,492 

About Cerevel Therapeutics Stock history

Cerevel Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cerevel is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cerevel Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cerevel Therapeutics stock prices may prove useful in developing a viable investing in Cerevel Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding162.1 M88.2 M
Net Loss-404.2 M-424.4 M

Cerevel Therapeutics Stock Technical Analysis

Cerevel Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Cerevel Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cerevel Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Equity Valuation Now

   

Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Module

Cerevel Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Cerevel Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Cerevel Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cerevel to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Cerevel Therapeutics is a strong investment it is important to analyze Cerevel Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cerevel Therapeutics' future performance. For an informed investment choice regarding Cerevel Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cerevel Therapeutics Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Cerevel Stock analysis

When running Cerevel Therapeutics' price analysis, check to measure Cerevel Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cerevel Therapeutics is operating at the current time. Most of Cerevel Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cerevel Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cerevel Therapeutics' price. Additionally, you may evaluate how the addition of Cerevel Therapeutics to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Is Cerevel Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cerevel Therapeutics. If investors know Cerevel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cerevel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.67)
Return On Assets
(0.25)
Return On Equity
(0.72)
The market value of Cerevel Therapeutics is measured differently than its book value, which is the value of Cerevel that is recorded on the company's balance sheet. Investors also form their own opinion of Cerevel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cerevel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cerevel Therapeutics' market value can be influenced by many factors that don't directly affect Cerevel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cerevel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cerevel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cerevel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.